CV Jo Lambert - SPIN · 2018. 6. 9. · Page 1 - Curriculum vitae of Jo L.W. Lambert Last update...

- Curriculum vitae of Jo L.W. Lambert

Last update 12072013

C U R R I C U L U M V I T A E

PERSONAL INFORMATION

Name Lambert Jo L.W. Address Zeedijk 414, bus 8, 8670 Koksijde-Oostduinkerke

BELGIUM Telephone 32/9/3322294

Fax 32/9/3324996 E-mail [email protected]

Nationality B

Date of birth 11/04/1968

EXPERTISE

• Principal areas of expertise

Dermatology (emphasis on research in pigmentation, psoriasis, patient education)

WORK EXPERIENCE

• Dates (from – to) 2000-2003 • Name and address of employer Ghent University Hospital, Belgium

• Type of business or sector Dermatology • Occupation or position held Staff position as Dermatologist and Doctor-Assistant

• Main activities and responsibilities

2003-2007 Ghent University Hospital Belgium Dermatology Professor, University Lecturer, Department of Dermatology and Director of the Dermatology Research Unit

• Dates (from – to) 2008-now • Name and address of employer Ghent University Hospital Belgium, Dpt of Dermatology

De Pintelaan 185 – 9000 Gent, Belgium • Type of business or sector Dermatology

• Occupation or position held Professor and Chair in Dermatology Full Professor in Dermatology Venerology (since October 2012)

• Main activities and responsibilities At present : Responsible for the Academic Department of Dermatology at UGent (about 70 people, with 18 dermatologists) and Dermatology Research Unit (promotor of research projects in psoriasis, transdermal drug delivery, pigmentation, and patient education) at UGent Coordinating University Trainer for Resident training in Derm Ven Board member and vice president of the Belgian Royal Society of Dermatology and Venereology Board member of the Royal Academy of Medicine Belgium Expert board member of several national and international psoriasis expert committees

• Dates (from – to) • Name and address of employer

• Type of business or sector • Occupation or position held

• Main activities and responsibilities



EDUCATION AND TRAINING

• Dates (from – to) 01061994-31052000

• Name and type of organization providing education and training

Ghent University Hospital

• Principal subjects/occupational skills covered

Residency in Dermatology-Venereology

• Title of qualification awarded MD and specialist in Dermatology-Venereology • Level in national classification

(if appropriate)

• Dates (from – to) 01011995-31121999

• Name and type of organization providing education and training

Ghent University

• Principal subjects/occupational skills covered

Melanosome transport in human skin pigmentation

• Title of qualification awarded PhD degree, obtained anno 2000 • Level in national classification

(if appropriate)

MOTHER TONGUE Dutch

English, French

• Reading skills Dutch, English, French

• Writing skills Dutch, English, French • Verbal skills Dutch, English, French

ADDITIONAL INFORMATION

Certificates in Mycology, Medical Statistics, Management Development

LANGUAGES

OTHER LANGUAGES



PUBLICATIONS

(a1) Articles in journals listed in Science Citation Index 1993 1. VERBRUGGEN G., MALFAIT A.M., VEYS E.M., GYSELBRECHT L., LAMBERT J., ALMQVIST K.F. Influence of Interferon-g on isolated chondrocytes from human articular cartilage. Dose Dependent Inhibition of Cell Proliferation and of Proteoglycan Synthesis. J Rheumatol. 20 : 1020-1026, 1993. 2. R.COUVREUR, G.JOOS, M.L.GEERTS, J.LAMBERT, J.M.NAEYAERT Neuron-specific enolase as serum marker for malignant melanoma. Lancet 342 : 985, 1993.

1994 3. MALFAIT A.M., VERBRUGGEN G., VEYS E.M., LAMBERT J., DE RIDDER L., CORNELISSEN M. Comparative and combined effects of interleukin-6, interleukin-1 and tumour necrosis factor-a on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheumatol.21 : 314-320, 1994. 1997 4. LAMBERT J., GOVAERT P., NAEYAERT JM. The Syndrome Page : Aplasia Cutis Congenita. Pediatr Dermatol. 14 : 4, 330-332, 1997 .

1998 5. J. LAMBERT, J.M. NAEYAERT, T. CALLENS, A. DE PAEPE, L. MESSIAEN. Human myosin V gene produces different transcripts in a cell type-specific manner. Biochem Biophys Res Commun 252 : 329-333, 1998. (IF = 2,780) Ranking = 12/57 (Biophysics)

6. J. LAMBERT, J. ONDERWATER, Y. VANDER HAEGHEN, G. VANCOILLIE, H.K. KOERTEN, A.M. MOMMAAS, J.M. NAEYAERT. Myosin V colocalizes with melanosomes and subcortical actin bundles not associated with stress fibers in human epidermal melanocytes. J Invest Dermatol 111 : 835-840, 1998. (IF = 4,822) Ranking : 1/35 (Dermatology & Venereal Diseases) 1999 7. JO LAMBERT, GARNET VANCOILLIE, JEAN MARIE NAEYAERT. Molecular motors and their role in pigmentation. Cell Mol Biol 45 : 905-918, 1999. IF = 1,172) Ranking = 99/141 (Cell Biology)

8. N. WIEME, J. LAMBERT , M. MOERMAN, M.L. GEERTS, L. TEMMERMAN, J.M. NAEYAERT. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid. Dermatology 198 : 310-313, 1999. (IF = 959) Ranking = 16/36 ((Dermatology & Venereal Diseases)

9. G. VANCOILLIE, J. LAMBERT, J.M. NAEYAERT. Melanocyte biology and its implications for the clinician : an update. Eur.J.Dermatol. 9 : 241-251, 1999. (IF = 0,846) Ranking : 32/36 (Dermatology & Venereal Diseases) 2000 10. GARNET VANCOILLIE, JO LAMBERT, YVES VANDERHAEGHEN, WENDY WESTBROEK, AAT MULDER, HENK K KOERTEN, A MIEKE MOMMAAS, PATRIC VAN OOSTVELDT, JEAN MARIE NAEYAERT. Colocalization of the dynactin subunits P150Glued and P50 with melanosomes in normal human melanocytes. Pigment Cell Res 13 : 449-457, 2000. (IF = 1,866) Ranking = 84/147 (Cell Biology) 11. GARNET VANCOILLIE, JO LAMBERT, AAT MULDER, HENK K KOERTEN, A MIEKE MOMMAAS, PATRIC VAN OOSTVELDT, JEAN MARIE NAEYAERT. Cytoplasmic dynein colocalizes with melanosomes in normal human melanocytes. Brit J



Dermatol 143 : 298-306, 2000. (IF = 2,214) Ranking = 5/36 (Dermatology & Venereal Diseases) 12. JO LAMBERT, JEAN MARIE NAEYAERT, ANNE DE PAEPE, LUDWINE MESSIAEN. Arg-Cys substitution at codon 1246 of the human myosin Va gene is not associated with Griscelli syndrome. J Invest Dermatol. 2000 Apr;114(4):731-3. (IF = 4,539) Ranking = 1/36 (Dermatology & Venereal Diseases) 13. GARNET VANCOILLIE, JO LAMBERT, AAT MULDER, HENK K. KOERTEN, A. MIEKE MOMMAAS, PATRIC VAN OOSTVELDT, JEAN MARIE NAEYAERT. Kinesin and kinectin can associate with the melanosomal surface and form a link with microtubules in normal human melanocytes. J Invest Dermatol 114 : 421-429, 2000. (IF = 4,539) Ranking = 1/36 (Dermatology & Venereal Diseases) 14. K.DHAENE, G.VANCOILLIE, J.LAMBERT, J.M.NAEYAERT, E.VAN MARCK. Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures. Brit J Cancer 82(5) : 1051-1057, 2000. (IF = 3,489) Ranking = 17/103 (Oncology)

15. GOETEYN V., NAEYAERT J.M., LAMBERT J., MONBALIU L., VERMANDER F. Is systemic autoimmune disease a risk factor for terbinafine-induced erythema multiforme? Brit J Dermatol 142 (3) : 578-579, 2000. (IF=2,214) Ranking = 5/36 (Dermatology & Venereal Diseases) 16. J.LAMBERT, G.VANCOILLIE, J.M.NAEYAERT. Elejalde syndrome revisited. Arch Dermatol 136, 120-121, 2000 (letter to the editor). (IF = 3,292) Ranking = 2/36 (Dermatology & Venereal Diseases) 2001 17. WENDY WESTBROEK, JO LAMBERT, JEAN MARIE NAEYAERT. The dilute locus and Griscelli syndrome : gateways towards a better understanding of melanosome transport. Pigment Cell Res 15 : 320-327, 2001. (IF = 2,102) Ranking = 78/147 (Cell Biology) 18. DEVULDER J, LAMBERT J, NAEYAERT JM. Gabapentin in pain control of cancer patients' wound dressing care. J Pain Symptom Manage 22 : 622-626, 2001. (IF = 2,119) Ranking = 4/48 (Health Care Sciences & Services) 2003 19. DE SCHEPPER S, LOEYS B, DE PAEPE A, LAMBERT J, NAEYAERT JM. Cutis Laxa of the autosomal recessive type in a consanguineous family. Eur J Dermatol 13(6) :529-33, 2003. IF=0,987) Ranking = 24/38 (Dermatology) 20. WESTBROEK W, LAMBERT J, BAHADORAN P, BUSCA R, MOMMAAS AM, SMIT N, NAEYAERT JM. Interactions of human myosin Va isoforms, endogenously expressed in human melanocytes, are tightly regulated by the tail domain. J Invest Dermatol 120 : 465-475, 2003. (IF = 4,194) Ranking = 1/38 (Dermatology) 21. BAHADORAN P, BUSCA R, CHIAVERINI C, WESTBROEK W, LAMBERT J, BILLE K, VALONY G, FUKUDA M, NAEYAERT JM, ORTONNE JP, BALLOTTI R. Characterisation of the molecular defects in RAB27A, caused by RAB27A missense mutations found in patients with Griscelli syndrome. J Biol Chem 278 : 11386-11392,2003. (IF = 6,482) Ranking = 31/261 (Biochemistry & Molecular Biology) 2004

22. WENDY WESTBROEK, JO LAMBERT, SOFIE DE SCHEPPER, ROBERT KLETA, KAROLIEN VAN DEN BOSSCHE, MIGUEL SEABRA, MARJAN HUIZING, MIEKE MOMMAAS, JEAN MARIE NAEYAERT. Rab27b is Up-Regulated in Human Griscelli syndrome type II Melanocytes and Linked to the Actin Cytoskeleton via Exon F-Myosin Va Transcripts. Pigment Cell Res 17: 1-8, 2004. Cowinner “PCR Outstanding Article for 2004”. (IF = 3,000) Ranking = 65/155 (Cell Biology) 2005



23. BERENS W, VAN DEN BOSSCHE K, YOON TJ, WESTBROEK W, VALENCIA JC, OUT CJ, NAEYAERT JM, HEARING VJ, LAMBERT J.

Different approaches for assaying melanosome transfer. Pigment Cell Res 18: 370-381, 2005. (IF= 2.679) Ranking = 70/153 (Cell Biology)

24. JOACHIM BOUCNEAU, SOFIE DE SCHEPPER, MARNIK VUYLSTEKE, PAUL VAN HUMMELEN, JEAN-MARIE NAEYAERT AND JO LAMBERT. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene. Pigment Cell Res 18: 285-299, 2005. (IF= 2.679) Ranking = 70/153 (Cell Biology)

25. SOFIE DE SCHEPPER, JOACHIM BOUCNEAU, JO LAMBERT, LUDWINE MESSIAEN, JEAN MARIE NAEYAERT. Pigment cell-related manifestations in neurofibromatosis type 1: an overview. Pigment Cell Res 18:13-24, 2005. (IF = 2.679) Ranking = 70/153 (Cell Biology)

2006

26. JORDENS I, WESTBROEK W, MARSMAN M, ROCHA N, MOMMAAS M, HUIZING M, LAMBERT J, NAEYAERT JM, NEEFJES J. Rab7 and Rab27a control two motor protein activities involved in melanosomal transport. Pigment Cell Res. 2006 19: 412-23, 2006. (IF = 3,180) Ranking = 3/39 (Dermatology)

27. VAN DEN BOSSCHE KAROLIEN, JEAN MARIE NAEYAERT, JO LAMBERT. The Quest for the Mechanism of Melanin Transfer. Traffic 7: 1-10, 2006. (IF = 6.612) Ranking = 28/156 (Cell Biology).

28. DE SCHEPPER S, BOUCNEAU JM, WESTBROEK W, MOMMAAS M, ONDERWATER J, MESSIAEN L, NAEYAERT JM, LAMBERT JL. Neurofibromatosis Type 1 Protein and Amyloid Precursor Protein Interact in Normal Human Melanocytes and Colocalize with Melanosomes. J Invest Dermatol 126: 653-9, 2006 + comment in J Invest Dermatol 126: 547-50, 2006. (IF= 4.535) Ranking = 1/39 (Dermatology)

29. S DE SCHEPPER, J BOUCNEAU, YVES VANDER HAEGHEN, L MESSIAEN, JM NAEYAERT, J LAMBERT. Café-au-lait spots in Neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind? Arch Dermatol Res 297: 439-49, 2006. (IF= 1.333) Ranking = 21/39 (Dermatology).

2007

30. BODE S, BAERT B, VAN GELE M, LAMBERT J, BURVENICH C, SLEGERS G, DE SPIEGELEER B. Stability of the OECD model compound benzoic acid in receptor fluids of Franz diffusion cells. Pharmazie (2007) 62: 470-471 (IF=0,775) Ranking = 176/205 (Pharmacology and Pharmacy) 31. LEROY JG, NUYTINCK L, LAMBERT J, NAEYAERT JM, MORTIER GR. Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene. Am J Med Genet A. (2007), 143:3144-9. (IF= 2,440) Ranking = 71/132 (Genetics and Heredity)

32. BAERT B, DECONINCK E, VAN GELE M, SLODICKA M, STOPPIE P, BODE S, SLEGERS G, VANDER HEYDEN Y, LAMBERTJ, BEETENS J, DE SPIEGELEER B. Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. Bioorg Med Chem (2007), 15, 6943-6955. (IF=2,662) Ranking = 11/56 (Chemistry, Organic)



33. SOFIE DE SCHEPPER, OPHÉLIA MAERTENS, TOM CALLENS, JEAN-MARIE NAEYAERT, JO LAMBERT, LUDWINE MESSIAEN. Somatic mutation analysis in NF1 café-au-lait spots reveals two NF1 hits in the melanocytes. J Invest Dermatol (2008), 128, 1050-1053. (IF=5,251) Ranking = 1/43 (Dermatology) 2008

34. MIREILLE VAN GELE, BARBARA GEUSENS, ANNE-MARIE SCHMITT, LUC AGUILAR, JO LAMBERT. Knockdown of myosin Va isoforms by exon-specific RNAi as a novel tool to block melanosome transport in primary human melanocytes. J. Invest. Dermatol. (2008), 128, 2474-2484. (IF=5,251) Ranking = 1/43 (Dermatology) 35. RACHAEL A. CLARK, SUSAN J. HUANG, GEORGE F. MURPHY, ILSE G. MOLLET, DIRKJAN HIJNEN, MANOJ MUTHUKURU, CARL F. SCHANBACHER, VONETTA EDWARDS, DANIELLE M. MILLER, JENNY E. KIM, JO LAMBERT, THOMAS S. KUPPER. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med. (2008), 205, 2221-2234. (IF= 15,463). Ranking = 3/83 (Medicine, Research and Experimental) 36. BOONE B, BLOKX W, DE BACQUER D, LAMBERT J, RUITER D, BROCHEZ L. The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Archives 453: 257-265, 2008 (IF=2.082) Ranking = 31/69 (Pathology) 2009 37. BOONE B, VAN GELE M, LAMBERT J, HASPESLAGH M, BROCHEZ L. The role of RhoC in growth and metastatic capacity of melanoma. J Cutan Pathol 36:629-636, 2009 (IF=1.486) Ranking = 27/48 (Dermatology) 38. B. GEUSENS, J. LAMBERT, S. DE SMEDT, N. SANDERS AND M. VAN GELE. Ultradeformable liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes (2009). J Control Release 133, 214-220. (IF=5.949). Ranking = 14/140 (Chemistry, multidisciplinary) 39. M. VAN GELE, P. DYNOODT AND J. LAMBERT. Griscelli syndrome: a model system to study vesicular trafficking. Pigment Cell Melanoma Res. 22: 268-282 (2009) (IF=4,344) Ranking= 3/48 (Dermatology) 40. GEUSENS B, SANDERS N, PROW T, VAN GELE M, LAMBERT J. Cutaneous short-interfering RNA therapy. Expert Opin. Drug Deliv. 6: 1333-1349, 2009 (IF= 3,345) Ranking= 61/227 (Pharmacology & Pharmacy) 2010 41. Y JIN, SA. BIRLEA, PR FAIN, K GOWAN, SL RICCARDI, PJ HOLLAND, CM MAILLOUX, AJD SUFIT, SM HUTTON, A AMADI-MYERS, DC BENNETT, MR WALLACE, WT MCCORMACK, EH KEMP, DJ GAWKRODGER, AP WEETMAN, M PICARDO, G LEONE, A TAÏEB, T JOUARY, K EZZEDINE, N VAN GEEL, J LAMBERT, A OVERBECK, RA SPRITZ. Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo. New Engl J Med, 362(18):1686-97, 2010 (IF=53,486) Ranking =1/153 (Medicine, General and Internal) 42. HENDRIX A, MAYNARD D, PAUWELS P, BRAEMS G, DENYS H, VAN DEN BROECKE R, LAMBERT J, VAN BELLE S, COCQUYT V, GESPACH C, BRACKE M, SEABRA M, GAHL WA, DE WEVER O, WESTBROEK W. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst, 102 : 1-15, 2010 (IF=14.697) Ranking =6/185 (Oncology) 43. NA VAN GEEL, IG MOLLET, S DE SCHEPPER, EPM TJIN, K VERMAELEN, RA CLARK, TS KUPPER, RM LUITEN, J LAMBERT. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigm Cell Melanoma Res 23: 375-84, 2010 (IF=4,750) Ranking =2/55 (Dermatology) 44. J LAMBERT, S BRACKE, F VAN ROY, HH PAS, S BONNE, S DE SCHEPPER. Serum plakophilin-3 autoreactivity in paraneoplastic pemphigus. Brit J Dermatol. (2010), 163, 630.632 (IF=4,353) Ranking = 3/55 (Dermatology) 45. MONA STÅHLE, NILGUN ATAKAN, WOLF-HENNING BOEHNCKE, SERGIO



CHIMENTI, ESTEBAN DAUDÉN, ALBERTO GIANNETTI, PETER HÖGER, PASCAL JOLY, ANDREAS KATSAMBAS, KNUD KRAGBALLE, JO LAMBERT, JEAN-PAUL ORTONNE, JÖRG PRINZ, LLUÍS PUIG, MARIEKE SEYGER, ROBERT STROHAL, PETER VAN DE KERKHOFF, WOLFRAM STERRY. Juvenile psoriasis and its clinical management : a European expert group consensus. J Dtsch Dermatol Ges. (2010) 8, 812-8 (IF=1,485) Ranking = 30/55 (Dermatology) 46. GEUSENS B, VAN GELE M, BRAAT S, DE SMEDT SC, STUART MCA, PROW T, SANCHEZ W, ROBERTS MS, SANDERS NN, LAMBERT J. Flexible Nanosomes (SECosomes) enable efficient siRNA delivery in Cultured Primary skin cells and in the viable epidermis of Ex Vivo Human Skin. Advanced Functional Materials. (2010), 20: 4077–90. DOI:10.1002/adfm.201000484. (IF(2010)=8,508) Ranking = 6/64 (Nanoscience & Nanotechnology) 47. JIN Y, BIRLEA SA, FAIN PR, MAILLOUX CM, RICCARDI SL, GOWAN K, HOLLAND PJ, BENNETT DC, WALLACE MR, MCCORMACK WT, KEMP EH, GAWKRODGER DJ, WEETMAN AP, PICARDO M, LEONE G, TAÏEB A, JOUARY T, EZZEDINE K, VAN GEEL N, LAMBERT J, OVERBECK A, SPRITZ RA. Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet 42:576-8, 2010. (IF=36,377) Ranking = 1/156 (Genetics and Heredity)

48. VAN GEEL N, WALLAEYS E, GOH BK, DE MIL M, LAMBERT J. Long term results of non cultured epidermal cellular grafting in vitiligo, halo nevi, piebaldism and nevus depigmentosus. Brit J Dermatol, (2010), 163, 1186-1193. (IF=4,353) doi: 10.1111/j.1365-2133.2010.10014.x. Ranking = 3/55 (Dermatology)

49. SPEECKAERT MM, SPEECKAERT R, LAMBERT J, BROCHEZ L. Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts. Eur J Dermatol 20: 4425-433, 2010. (IF=2,421) Ranking = 15/55 (Dermatology)

2011 50. VAN GEEL N, DE LILLE S, VANDENHAUTE S, GAUTHIER Y, MOLLET I, BROCHEZ L, LAMBERT J. Different phenotypes of segmental vitiligo based on a clinical observational study. J Eur Acad Derm Ven 25(6):673-8, 2011. (IF (2010) 3,309) Ranking = 10/55 (Dermatology) 51. BIRLEA SA, JIN Y, BENNETT DC, HERBSTMAN DM, WALLACE MR, MCCORMACK WT, KEMP EH, GAWKRODGER DJ, WEETMAN AP, PICARDO M, LEONE G, TAÏEB A, JOUARY T, EZZEDINE K, VAN GEEL N, LAMBERT J, OVERBECK A, FAIN PR, SPRITZ RA. Comprehensive Association Analysis of Candidate Genes for Generalized Vitiligo Supports XBP1, FOXP3, and TSLP. J Invest Dermatol 131:371-81, 2011. (IF(2010)=6.270) Ranking = 1/55 (Dermatology) 52. SPEECKAERT R, VAN GEEL N, VERMAELEN KV, LAMBERT J, VAN GELE M, SPEECKAERT MM, BROCHEZ L. Immune reactions in benign and malignant melanocytic lesions : lessons for immunotherapy. Pigment Cell Melanoma Res 24(2):334-44, 2011 (IF(2010)=4.750) Ranking = 2/55 (Dermatology) 53 VAN GEEL N, VANDENHAUTE S, SPEECKAERT R, BROCHEZ L, MOLLET I, DE COOMAN L, LAMBERT J. Prognostic value and clinical significance of halo nevi regarding vitiligo. Br J Dermatol (2011), 164, 743-749. (IF(2010)= 4.353 ) Ranking = 3/55 (Dermatology)

54. LAMBERTJ, BOSTOEN J, GEUSENS B, BOURGOIS J, BOONE J, DE SMEDT D, ANNEMANS L. A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results. Arch Derm Res 303: 57-63, 2011. (IF(2010)=2.011) Ranking = 20/55 (Dermatology)

55. JIN Y, BIRLEA SA, FAIN PR, GOWAN K, RICCARDI SL, HOLLAND PJ, BENNETT DC, HERBSTMAN DM, WALLACE MR, MCCORMACK WT, KEMP EH, GAWKRODGER DJ, WEETMAN AP, PICARDO M, LEONE G, TAÏEB A, JOUARY T, EZZEDINE K, VAN GEEL N, LAMBERT J, OVERBECK A, SPRITZ RA. Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol. (2011), 131, 1308-1312. (IF(2010)=6.270) Ranking = 1/55 (Dermatology)



56. BOONE B, JACOBS K, FERDINANDE L, TAILDEMAN J, LAMBERT J, PEETERS M, BRACKE M, PAUWELS P, BROCHEZ L. EGFR in melanoma: clinical significance and potential therapeutic target. J Cutan Pathol 38:492-502, 2011. (IF(2010)=1.744) Ranking = 26/55 (Dermatology) 57. VAN GELE MIREILLE, GEUSENS BARBARA, BROCHEZ LIEVE, SPEECKAERT REINHART, LAMBERT JO. 3D skin models as tools for transdermal drug delivery: challenges and limitations. Expert Opin Drug Deliv 8(6):705-720, 2011. (IF(2010)=4,482) Ranking = 32/252 (Pharmacology & Pharmacy) 58. VAN GEEL N, GOH BK, WALLAEYS E, LAMBERT J. A review of non-cultured epidermal cellular grafting in vitiligo. J Cut Aesth Surg 4 : 17-22, 2011. 59. B. GEUSENS, T. STROBBE, S. BRACKE, P. DYNOODT, N.N. SANDERS, M. VAN GELE, J. LAMBERT. Lipid-mediated Gene Delivery to the Skin. Eur J Pharm Sci, 43(4):199-211, 2011. (IF(2010)=3,291) Ranking = 68/252 (Pharmacology & Pharmacy)

60. SPEECKAERT R, BROCHEZ L, LAMBERT J, VAN GEEL N, SPEECKAERT M, CLAEYS L, LANGLOIS M, VAN LAER C, PEETERS P, DELANGHE J. The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients. J Eur Acad Derm Venerol (2011) May 17. doi: 10.1111/j.1468-3083.2011.04112.x. [Epub ahead of print] (IF(2010) =2.780) Ranking = 11/55 (Dermatology)

61. M. VAN GELE, B. GEUSENS, R. SPEECKAERT, P. DYNOODT, B. VANHOECKE, K. VAN DEN BOSSCHE, and J. LAMBERT. Development of a 3D pigmented skin model to evaluate RNAi-induced depigmentation. Exp Dermatol 20 : 773-775, 2011. (IF(2010)=4,159) Ranking = 6/55 (Dermatology)

62. BOONEN J, BAERT B, LAMBERT J, DESPIEGELEER B. Skin penetration of silica microparticles. Pharmazie 66(6):463-4, 2011. (IF(2010)=0,869) Ranking = 85/147 (Chemistry, multidisciplinary)

63. VAN GEEL N, SPEECKAERT R, LAMBERT J, MOLLET I, DE KEYSER S, DE SCHEPPER S, BROCHEZ L. Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis. J Eur Acad Dermatol Venereol. 2011 Jun 23. doi: 10.1111/j.1468-3083.2011.04160.x. [Epub ahead of print]. (IF(2010) =2.780) Ranking = 11/55 (Dermatology)

64. VAN GEEL N, MOLLET I, BROCHEZ L, DUTRE M, DE SCHEPPER S, VERHAEGHE E, LAMBERT J, SPEECKAERT R. New insights in segmental vitiligo : case report and review of theories. Brit J Dermatol, 2011) Sep 21. doi: 10.1111/j.1365-2133.2011.10650.x. [Epub ahead of print] (IF(2010) = 4.353) Ranking = 3/55 (Dermatology)

65. SPEECKAERT R, VERMAELEN K, VAN GEEL N, AUTIER P, LAMBERT J, HASPESLAGH M, VAN GELE M, THIELEMANS K, NEYNS B, ROCHE N, VERBEKE N, DERON P, SPEECKAERT M, BROCHEZ L. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients. Eur J Cancer. 2011 Oct 25. Epub ahead of print. (IF(2010) = 4.944) Ranking= 31/185 (Oncology)

2012

66. VAN GEEL NANJA, SPEECKAERT REINHART, MOLLET ILSE, DE SCHEPPER SOFIE, DE WOLF JULIE, TJIN ESTHER, LUITEN ROSALIE, LAMBERT JO, BROCHEZ LIEVE. In vivo vitiligo induction and therapy model : double blind, randomized clinical trial. Pigment Cell Melanoma Research (2012) Jan 25(1): 57-65. (IF(2010) = 4.750) Ranking = 2/55 (Dermatology)

67. SPEECKAERT R, VAN GEEL N, LUITEN RM, VAN GELE M, SPEECKAERT M, LAMBERT J, VERMAELEN K, TJIN EPM, BROCHEZ L. Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma. Anticancer Research 31: 3697-3703, 2011. (IF (2010)= 1,656) Ranking= 136/185 (Oncology)

68. VERHAEGHE E, LODEWICK E, VAN GEEL N, LAMBERT J. Intrapatient



comparison of 308-nm monochromatic excimer light and localized narrow-band UVB photography in the treatment of vitiligo : a randomized controlled trial. Dermatology, DOI:10.1159/000335272. (IF (2010)= 2,714) Ranking = 12/40 (Dermatology)

69. SPEECKAERT R, SPEECKAERT MM, LAMBERT J, BOONE B, VAN GEEL N, BROCHEZ L. Examples of immune mediated mechanisms of melanocyte destruction paving the way for efficiënt immunotherapeutic strategies. OncoImmunology 1(4):526-528, 2012.

70. VAN GEEL N, SPEECKAERT R, DE WOLF J, BRACKE S, CHEVOLET I, BROCHEZ L, LAMBERT J Clinical significance of Koebner’s phenomenon in vitiligo. Accepted Br J Dermatol 2012 (IF = 4.353)

71. JIN Y, BIRLEA SA, FAIN PR, FERRARA TM, BEN S, RICCARDI SL, COLE JB, GOWAN K, HOLLAND PJ, BENNETT DC, LUITEN RM, WOLKERSTORFER A, VAN DER VEEN JPW, HARTMANN A, EICHNER S, SCHULER G, VAN GEEL N, LAMBERT J, KEMP EH, GAWKRODGER DJ, WEETMAN AP, TAÏEB A, JOUARY T, EZZEDINE K, WALLACE MR, MCCORMACK WT, PICARDO M, LEONE G, OVERBECK A, SILVERBERG NB & SPRITZ RA. Genome-wide association study and meta-analysis identifies 13 new melanocyte-specific and immunoregulatory susceptibility loci for generalized vitiligo. Nature Genetics 44(6):676-80, 2012. (IF = 34.284)

72. BOSTOEN J, BRACKE S, DE KEYSER S, LAMBERT J. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. Br J Dermatol, 167(5):1025-31, 2012

73. TERRAS S, GAMBLICHER T, ALTMEYER P, LAMBERT J. Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses. Accepted for publication in Int J Dermatol, July 2012.

74. VAN GEEL N, SPEECKAERT R, MELSENS E, TOELLE SP, SPEECKAERT M, DE SCHEPPER S, LAMBERT J, BROCHEZ L. The distribution pattern of Segmental Vitiligo: clues for somatic mosaicism. Brit J Dermatol, accepted August 2012. doi: 10.1111/bjd.12013.

75. BORDERE A, STOCKMAN A, BOONE B, FRANKI AS, COPPENS MJ, LAPEERE H, LAMBERT J. A case of anaphylaxis caused by macrogol 3350 after injection of a corticosteroid. Contact Dermatitis 67 : 375-385, 2012.

76. VAN GEEL N, SPEECKAERT R, DE WOLF J, BRACKE S, CHEVOLET I, BROCHEZ L, LAMBERT J. Clinical significance of Koebner phenomenon in vitiligo. Br J Dermatol 167:1017-24, 2012.

77. VERHAEGHE E, ONGENAE K, DIERCKXSENS L, BOSOTOEN J, LAMBERT J. Nonablative fractional laser resurfacing for the treatment of scars and grafts after Mohs micrographic surgery : a randomized controlled trial. J Eur Acad Dermatol Venereol 2012 Jul 4. Doi: 10.1111/j.1468-3083.2012.04639.x.

78. VERHAEGHE E, ONGENAE K, BOSTOEN J, LAMBERT J. Nonablative Fractional Laser Resurfacing for the Treatment of Hypertrophic Scars: A Randomized Controlled Trial. Dermatol Surg. 2012 Dec 26. doi: 10.1111/dsu.12059. [Epub ahead of print]

2013

79. BONNY M; AERTS O, LAMBERT J, LAMBERT J, LAPEERE H. Occupational contact allergy caused by Pao ferro (Santos rosewood) : a report of 2 cases. Contact Dermatitis 68 : 126-128, 2013.

80. BRACKE S, SPEECKAERT R, VAN GEEL N, DE BACQUER D, LAMBERT J. Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study. Eur J Dermatol. 2013 Jan 10. [Epub ahead of print] 81. DYNOODT P, MESTDAGH P, VAN PEER G, VANDESOMPELE J, GOOSSENS K, PEELMAN LJ, GEUSENS B, SPEECKAERT RM, LAMBERT JL, VAN GELE MJ. Identification of miR-145 as a Key Regulator of the Pigmentary Process. J Invest



Dermatol 133 : 201-209, 2013.

82. BOSTOEN J, VAN PRAET L, BROCHEZ L, MIELANTS H, LAMBERT J. A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis. J Eur Acad Dermatol Venereol 2012, accepted.

83. S. BRACKE, E. DESMET, S. GUERRERO-ASPIZUA, S. G. TJABRINGA, J. SCHALKWIJK, M. VAN GELE, M. CARRETERO, J. LAMBERT. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model. Arch Dermatol Res DOI 10.1007/s00403-013-1379-9, 2013.

84. DYNOODT P, SPEECKAERT R, DE WEVER O, CHEVOLET I, BROCHEZ L, LAMBERT J, VAN GELE M. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. Int J Oncology, DOI: 10.3892/ijo.2013.1823, 2013.

(b2) Chapters in books 1. H. LAPEERE, B. BOONE, S. DE SCHEPPER, E. VERHAEGHE, K. ONGENAE,

N. VAN GEEL, J. LAMBERT, L. BROCHEZ, J.M. NAEYAERT†. Hypomelanosis and hypermelanosis. In Fitzpatrick’s Dermatology In General Medicine, 7th Edition, 2008.

2. I MOLLET, N VAN GEEL, J LAMBERT. Autoimmune, Inflammatory and Other Diseases Associated with Vitiligo? Section I-3: Clinical Aspects. In Springer Handbook ‘Vitiligo’ ; Picardo, Mauro; Taïeb, Alain (Eds.) 2010, XVIII, 486 p. 161 illus., 144 in color., Hardcover. ISBN: 978-3-540-69360-4

3. N VAN GEEL, I MOLLET, B BOONE, J LAMBERT. Section III-4b Calcineurin inhibitors. In Springer Handbook ‘Vitiligo’ ; Picardo, Mauro; Taïeb, Alain (Eds.) 2010, XVIII, 486 p. 161 illus., 144 in color., Hardcover. ISBN: 978-3-540-69360-4

4. H. LAPEERE, B. BOONE, S. DE SCHEPPER, E. VERHAEGHE, K. ONGENAE, N. VAN GEEL, M. VAN GELE, J. LAMBERT, L. BROCHEZ, J.M. NAEYAERT†. Hypomelanosis and hypermelanosis. In Fitzpatrick’s Dermatology In General Medicine, 8th Edition, Section 11, Chapter 73, 2011.

5. M. VAN GELE AND J. LAMBERT. Transport and distribution of melanosomes. In: Melanins & Melanosomes. Biosynthesis, Structure, Physiological and Pathological Functions (978-3-527-32892-5); P. Riley and J. Borovansky (Eds.), 2011, WILEY-VCH, Weinheim, Germany.

6. GEUSENS B, MOLLET I, ANDERSON C, TERRAS S, ROBERTS M, LAMBERT J. “Changes in skin immunity with age and disease” in “Innate Immune System of Skin and Oral Mucosa: Properties and Impact in Pharmaceutics, Cosmetics, and Personal Care Products” – 2011, Published by Wiley, ed. Nava Dayan, Philippe W. Wertz– ISBN 9780470437773.

7. J LAMBERT, D VAN GOUBERGEN. Lean als de verbeterstrategie voor de polikliniek Dermatologie UZ Gent. In “Lean denken en doen in de zorg”, p 43-56, 2010. Eds Benders, Rouppe van der Voort, Berden, Uitgeverij LEMMA – ISBN 978-90-5931-525-9.

(c2) Patents and trademarks

Patentaanvraag met als nummer WO2007/068704 A1, gepubliceerd op 21 juni 2007. Titel: Anti-myosin Va siRNA and skin depigmentation. Uitvinders: Anne-Marie Schmitt, Wendy Westbroek, Jo Lambert en Mireille Van Gele

Benelux trademark application ‘OnderHUIDs’ 1 169 285, in klassen 41 en 44, publicatiedatum van de inschrijving 10.02.2009. Kenmerken van de gemachtigde : T1292-BX. Jo Lambert

Cationic liposomes for delivery of high molecular weight compounds. US provisional patent 61/220857, 26/06/2009 en PCT octrooiaanvraag met nr PCT/EP2010/059102 (UGent ref: P09/028 – SECosomes) Uitvinders : Barbara Geusens, Jo Lambert, Niek Sanders

CV Jo Lambert - SPIN · 2018. 6. 9. · Page 1 - Curriculum vitae of Jo L.W. Lambert Last update...

Documents

Transcript of CV Jo Lambert - SPIN · 2018. 6. 9. · Page 1 - Curriculum vitae of Jo L.W. Lambert Last update...